Charles D. Hyman’s Sonnet BioTherapeutics SONN Stock Holding History

Charles D. Hyman’s Portfolio SONN Stock Details SONN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Hold	0	–	-$16K	–	157
2017 Q1	–	Hold	0	–	–	–	146
2016 Q4	–	Hold	0	–	–	–	140
2016 Q3	–	Hold	0	–	–	–	139
2016 Q2	–	Hold	0	–	–	–	142
2016 Q1	–	Hold	0	–	–	–	139
2015 Q4	–	Hold	0	–	–	–	141
2015 Q3	–	Hold	0	–	–	–	143
2015 Q2	–	Hold	0	–	–	–	143
2015 Q1	–	Hold	0	–	–	–	143
2014 Q4	–	Hold	0	–	–	–	143
2014 Q3	–	Hold	0	–	–	–	140
2014 Q2	–	Hold	0	–	–	–	142
2014 Q1	–	Hold	0	–	–	–	137
2013 Q4	–	Hold	0	–	–	–	126
2013 Q3	–	Hold	0	–	–	–	129
2013 Q2	–	Hold	0	–	–	–	132

Other funds holding SONN

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return